In addition to the aforementioned effect, MVP is known to mediate multidrug resistance in a variety of cancer types including lung, ovarian and prostate cancers, although the effect is cell-type specific [28,119,122,123,131,136,145,146]. Here, MVP is linked to prostate carcinoma.